Nordhealth AS Statistics
Total Valuation
Nordhealth AS has a market cap or net worth of NOK 2.80 billion. The enterprise value is 2.57 billion.
Market Cap | 2.80B |
Enterprise Value | 2.57B |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Nordhealth AS has 79.07 million shares outstanding.
Current Share Class | 44.07M |
Shares Outstanding | 79.07M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 48.61% |
Owned by Institutions (%) | 18.99% |
Float | 38.15M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 75.80 |
PS Ratio | 5.21 |
PB Ratio | 3.23 |
P/TBV Ratio | 12.56 |
P/FCF Ratio | n/a |
P/OCF Ratio | 128.77 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -28.45 |
EV / Sales | 4.78 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -68.83 |
Financial Position
The company has a current ratio of 2.99
Current Ratio | 2.99 |
Quick Ratio | 2.87 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -208.81 |
Financial Efficiency
Return on equity (ROE) is -9.81% and return on invested capital (ROIC) is -6.17%.
Return on Equity (ROE) | -9.81% |
Return on Assets (ROA) | -5.52% |
Return on Invested Capital (ROIC) | -6.17% |
Return on Capital Employed (ROCE) | -10.46% |
Revenue Per Employee | 1.31M |
Profits Per Employee | -219,613 |
Employee Count | 411 |
Asset Turnover | 0.52 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.60% in the last 52 weeks. The beta is 0.44, so Nordhealth AS's price volatility has been lower than the market average.
Beta (5Y) | 0.44 |
52-Week Price Change | +7.60% |
50-Day Moving Average | 37.52 |
200-Day Moving Average | 37.61 |
Relative Strength Index (RSI) | 42.12 |
Average Volume (20 Days) | 3,231 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Nordhealth AS had revenue of NOK 537.23 million and -90.26 million in losses. Loss per share was -1.14.
Revenue | 537.23M |
Gross Profit | 184.25M |
Operating Income | -90.87M |
Pretax Income | -78.08M |
Net Income | -90.26M |
EBITDA | -10.24M |
EBIT | -90.87M |
Loss Per Share | -1.14 |
Balance Sheet
The company has 230.79 million in cash and n/a in debt, giving a net cash position of 230.79 million or 2.92 per share.
Cash & Cash Equivalents | 230.79M |
Total Debt | n/a |
Net Cash | 230.79M |
Net Cash Per Share | 2.92 |
Equity (Book Value) | 866.06M |
Book Value Per Share | 10.95 |
Working Capital | 213.21M |
Cash Flow
In the last 12 months, operating cash flow was 21.74 million and capital expenditures -59.04 million, giving a free cash flow of -37.31 million.
Operating Cash Flow | 21.74M |
Capital Expenditures | -59.04M |
Free Cash Flow | -37.31M |
FCF Per Share | -0.47 |
Margins
Gross margin is 34.30%, with operating and profit margins of -16.92% and -16.80%.
Gross Margin | 34.30% |
Operating Margin | -16.92% |
Pretax Margin | -14.53% |
Profit Margin | -16.80% |
EBITDA Margin | -1.91% |
EBIT Margin | -16.92% |
FCF Margin | n/a |
Dividends & Yields
Nordhealth AS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -3.22% |
FCF Yield | -1.33% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Nordhealth AS has an Altman Z-Score of 14.16.
Altman Z-Score | 14.16 |
Piotroski F-Score | n/a |